We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Advanced Digital Pathology System Enters Service in the United Kingdom

By LabMedica International staff writers
Posted on 20 Dec 2015
A major British hospital has incorporated an advanced digital pathology system, which is expected to increase diagnostic accuracy as well as streamlining the performance of the pathology department.

Digital pathology takes the traditional pathology workflow—slides and microscopes—and uses scanners and software to digitize slides. More...
With digitized slides, pathologists can examine high-resolution digital pathology workflow images with the aid of precision software tools. Pathologists can review case files with the slide image still in full view, and notes can be linked to specific areas of interest. Images and comments can be shared between healthcare teams with the same ease as sending an email.

Pathologists at University Hospitals Coventry and Warwickshire NHS Trust (United Kingdom) have begun to operate the Omnyx (Pittsburgh, PA, USA) Precision Solution digitalized pathology system. This state-of-the-art technology enables pathologists to accurately grade some types of tumors, including lung, prostate, and bladder tumors. In the first stage of adapting the system, more than 10,000 slides were examined in a study that showed that pathologists were as accurate diagnosing cancer with a computer as they had been with a microscope.

First author Dr. David Snead, professor of pathology at University Hospitals Coventry and Warwickshire NHS Trust, said, “I am delighted that University Hospital, Coventry has led this ground breaking study. This provides even greater evidence that digital pathology really works, and works well. The introduction of digital pathology has fantastic potential benefits for patients. We can expect to be able to read samples more quickly than before, and the big advantage is that we can use the computer to easily manipulate an image or its data. For some patients, this additional information may change how their disease is managed.”

Mamar Gelaye, CEO of Omnyx, said, “Dr. Snead and his team have made a significant contribution to showing the value of digital pathology for both clinicians and patients. We are only at the beginning of harnessing the benefits of digitizing pathology services, and we look forward to working with institutions like University Hospitals Coventry and Warwickshire NHS Trust to achieve even greater progress in delivering more accurate and efficient cancer diagnoses.”

The study was published in the December 6, 2015, online edition of the journal Histopathology.

Related Links:

University Hospitals Coventry and Warwickshire NHS Trust
Omnyx



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.